Posted on

The Secretary of Health (SOH) acknowledges the final recommendation of the HTA Council on ticagrelor (90 mg film-coated tablet) as an add-on to aspirin for adults with Acute Coronary Syndrome (ACS) (date of receipt of acknowledgment: 13 January 2026). As a final recommendation, the HTA Council does not recommend the government financing of ticagrelor as an add-on to aspirin for adults with ACS.

For further details, please refer to the documents below:

[HTAC Final Recommendation] Ticagrelor as add-on to aspirin for ACSDownload
[Evidence Considered] Ticagrelor (90mg film-coated tablet) as an add-on to aspirin for adults with acute coronary syndrome (ACS).pptx (1)Download